Important Tips for Avoiding Heat Exhaustion

135 views

Warm summer weather and prolonged sun exposure can lead to dehydration and heat exhaustion, both of which are especially dangerous for older adults. Seniors should follow these tips for staying safe this summer.Heat exhaustion can affect people of all ages, but older adults may be more susceptible to this issue. This can lead to a number of adverse health problems, and even cause heat stroke. For anyone planning on spending extended periods of time outdoors this summer, it is essential be aware of the causes and symptoms of heat exhaustion. To stay safe this summer, follow these important tips.

Spotlight

Akira

Akira is reimagining Canadian healthcare — we're changing how healthcare is delivered and empowering patients to be engaged and proactive about their health. Right Health combines virtual and face-to-face care to offer on-demand, accessible healthcare convenience at your fingertips. Akira is the technology platform within Right Health’s offering that provides you with an instant connection to great Canadian doctors, nurse practitioners, and more

OTHER ARTICLES
HEALTH TECHNOLOGY

Wearable Technology: A Pool of Opportunities in Healthcare

Article | June 22, 2022

Introduction The field of smart wearable devices has advanced significantly in recent years as a result of the advent of mobile medicine, the development of new technologies like smart sensing, and the increased penetration of personalized health concepts. These Internet of Things (IoT)-based smart devices not only help people pursue a healthier lifestyle, but also offer a constant flow of healthcare data, which can be used for disease diagnosis and treatment, by actively recording, tracking, and monitoring metabolic status and physiological parameters. Wearable technologies have the potential to completely change the ways to monitor health behavior and are increasingly finding clinical implementation for patients with various types of diseases. Wearable Technology: New Ways of Patient Monitoring While wearable technology has demonstrated value in the fields of entertainment, fitness, and gaming, it is making inroads into the healthcare industry at a rapid pace. Increasing advancements in sensor technology and artificial intelligence (AI) are assisting millions of people in detecting and managing chronic health conditions and avoiding serious illnesses using devices that are as small as a patch the size of a penny or small enough to be worn on the wrist. According to a study, nearly 320 million consumer health and wellness wearable devices are estimated to be shipped across the globe in 2022, and the number is likely to surpass 440 million units as a number of new devices come out and more healthcare providers start using them. Most wearable devices, such as smartwatches, now include heart rate monitors, and some have FDA approval for detecting abnormalities such as atrial fibrillation, a major cause of stroke. As these devices become more intelligent, the percentage of patients and consumers who use them to manage chronic health conditions and diagnose symptoms of serious diseases is likely to rise. This is expected to assist the sales of wearable devices in healthcare to exceed $195 billion by the end of 2027, presenting huge prospects for healthcare equipment providers and associated companies to benefit from the opportunity. The Future of Wearable Technology in Healthcare Though wearable technology is experiencing rapid growth, the field is still considered to be in its nascent stage, presenting massive remunerative prospects for the manufacturers of smart devices, especially in the healthcare industry. Hence, companies of all kinds, from giants to upstarts, are emphasizing on investing and developing new wearable devices with new features and functionalities to meet the surging demand for wearables across healthcare in coming years.

Read More
HEALTH TECHNOLOGY

The Long-Term Care Software: Mapping the Future

Article | July 19, 2022

Long-term care comprises all the health services that help patients with chronic illnesses or disabilities meet their medical and non-medical needs. It caters to those who cannot care for themselves for extended durations. For care providers, it becomes critical to meet the needs of patients on time while delivering top-notch quality, especially at a time when virtual care is more important than ever. To remedy this, many of the tasks and processes within long-term care are supported by digital solutions. These long-term care software applications enable care providers to automate aspects of patient scheduling, inventory control, regulation and compliance, data management, care delivery management, and much more. Some of the end users of long-term care software include home healthcare agencies, nursing homes, and residential hospice care facilities. What is Driving the Growth of Long-Term Care Solutions? Digitalization has swept the healthcare industry, and medical technology now occupies a significant area of medical care delivery. With the demand for a robust healthcare infrastructure aggravated by a shortage of medical professionals, the need for automation is driving the growth of medtech across all areas of healthcare. In addition, fewer medical specialists and medical cost reduction initiatives combined are powering the long-term care software market’s growth. Challenges for the Long-Term Care Software Market Despite the rapid growth in the use of digital solutions to manage administrative and compliance tasks, technological transformations are expensive. The high maintenance costs incurred by care providers are a major hindrance towards a full-fledged adoption. Many care providers are also unwilling to adopt new applications due to the implementation and staff training costs involved in doing so. What the Future Holds? With an increase in remote care and the use of technologies like the Internet of Medical Things to deliver diagnostic services and preventive care, medtech is witnessing a revolution. Long-term care is bound to follow suit thanks to areas like remote patient monitoring and wearable technology. While the long-term care market is slated to grow by leaps and bounds, solution makers must find a way to help care providers warm up to the use of technology and de

Read More
HEALTH TECHNOLOGY

Amazon Care: Revolutionizing Virtual Care

Article | July 13, 2022

In 2021, the introduction of Amazon Care marked the first time a prominent technology firm stepped into the healthcare services industry. The fact that Amazon filed paperwork to offer care in multiple states without much fanfare is intriguing. In March 2021, the company confirmed the details of its new services, announcing that it would be delivering the services through an independent private medical practice called Care Medical. The move may signify another diversification for Amazon, but what does it mean for the healthcare services landscape? The Highlights of Amazon Care’s Services Home healthcare Amazon announced that it would be participating in an advocacy group for home healthcare. The Moving Health at Home initiative aims to transform how policymakers view the home as a site to deliver clinical services. Amazon Care may be riding on the trend for home care that has been evolving in the form of remote patient monitoring for post-acute care management and chronic care. Employer-oriented offering Amazon Care aims to become a workplace benefit partner for employers. One of the pain points it is directly addressing is the challenge of runaway inflation that increases healthcare costs. Virtual care simplified The most significant offering that Amazon Care plans to lead with is virtual care that promises to reduce wait times for quality patient care to under 60 seconds. It also includes the option to access 24-hour care services through messaging and video calling. In addition, it eliminates unnecessary traveling and long wait times by delivering care in the comfort of the patient’s home. The Path Ahead Amazon is known for introducing a slew of initiatives in the health and fitness sector, like the Halo wearables, a data management product called Amazon Health Lake, and a healthcare delivery system called Haven, which doubled over in 2021 after a three-year run. However, the tech juggernaut is not about to stop attempting to disrupt healthcare services. Only time will tell whether Amazon Care finally proves to be a feather in Amazon’s healthcare cap or another ambitious project that bites the dust.

Read More
HEALTH TECHNOLOGY

3 IT Investment Strategies Hospitals Can Use to Improve Patient Care

Article | July 5, 2022

Rural, community, and independent hospitals are constantly facing mounting challenges in the form of staff shortages, accessibility to patient care and a multitude of cost concerns. Getting even one of these areas under control can help hospitals drastically boost their outcomes. Here are three areas of IT investment that hospitals must control to go beyond staying functional and create an excellent patient experience. Telehealth for Staff Shortage Healthcare currently face massive staff shortage with a projected gap of up to 48,000 primary care physicians and up to 77,100 specialty physicians till 2034. The effects of this shortage could be lessened by using virtual care, which would allow hospitals to care for patients through remote staffing. Digitalizing Patient Care with Asynchronous Telehealth Async telehealth of patients sending photos and videos to fast-track diagnosis. Async telehealth makes it easier for doctors to connect with more patients. This shortens the time it takes to see specialists and get important care services. Remote Patient Monitoring According to a CDC report, 90% of all healthcare spending goes into treating chronic conditions. Considering that U.S. nonmetropolitan areas have a high number of patients diagnosed with chronic conditions, accessibility is one of the contributing factors. Remote patient monitoring enhances patient care for people with chronic conditions. Wearable medical devices are already driving the move towards remote patient monitoring. Whether it’s through wearable weight scales, heart monitors, blood pressure bands, or pulse oximeters, clinicians can generate regular updates about a patient’s health readings and ensure a timely response in order to avert complications. Conclusion There is much to be achieved on the healthcare front when it comes to digitalizing care. The above technologies are enabling healthcare providers take delivery of medical care further than ever and ensure they generate more traction from their IT investments in these areas of medtech.

Read More

Spotlight

Akira

Akira is reimagining Canadian healthcare — we're changing how healthcare is delivered and empowering patients to be engaged and proactive about their health. Right Health combines virtual and face-to-face care to offer on-demand, accessible healthcare convenience at your fingertips. Akira is the technology platform within Right Health’s offering that provides you with an instant connection to great Canadian doctors, nurse practitioners, and more

Related News

DIGITAL HEALTHCARE

Lucira Health Announces Expanded Partnership with Switch Health to Increase Canadians' Access to At-Home Molecular COVID-19 Tests

Lucira Health | December 27, 2021

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced a new agreement with Switch Health Solutions Inc. ("Switch Health") to increase Canadians' access to at-home molecular COVID-19 tests as Omicron cases surge. Lucira will provide more than 2 million at-home COVID-19 test kits in 2022 as part of the deal. "As Omicron cases surge around the world, the need for better testing solutions has never been more apparent. Only Lucira's tests provide a PCR-quality test result in 30 minutes, wherever you are, from a simple, single-use kit. Making these tests more available is critical to help slow the spread of COVID-19." Erik Engelson, President and Chief Executive Officer of Lucira Switch Health is a Canadian healthcare company dedicated to providing better decentralized patient care. Switch Health has quickly become a leader in COVID-19 testing on-site at its Switch Health Clinics and at-home through its remote telehealth service and in-person visits. "Switch Health's ability to be a Canadian health care leader in decentralized diagnostics is in large part due to the innovative technologies we make available to everyday Canadians," added Marc Thomson, Chief Operating Officer at Switch Health. "Lucira has been an instrumental partner in helping Switch Health achieve that in the COVID-19 era. Together, we are removing barriers to get Canadians safely back to work and reunited with their loved ones." Last month, Lucira announced confirmation that its COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' can detect 100% of Omicron variant genome sequences analyzed, including the "stealth variant." Lucira assays target viral sequence regions unaffected by the spike protein mutations found in Omicron, Delta, and other variants of concern, allowing it to maintain its accuracy in the face of an evolving virus. Lucira has received Interim Order authorization from Health Canada to sell and distribute its COVID-19 test kits for at-home self-testing in Canada. LUCIRA™ CHECK IT Test Kit The Lucira™ Check-It (OTC) and All-in-One (Rx) test kits are Nucleic-Acid Amplification Tests (referred to as NAAT). The tests fit in the palm of your hand, extract genetic material from the virus and amplify it, similar to PCR lab tests, to detect the presence of virus earlier and more accurately than antigen tests. The test uses an approach called reverse transcriptase loop-mediated isothermal amplification (RT-LAMP). It was designed and tested extensively for individuals to use independently and does not require a physician's prescription or supervised assistance. There is no additional equipment to purchase, such as a reader or instrument. Each Lucira test kit contains everything needed to run one COVID-19 test. Users get the test device, two AA batteries, sample vial, swab and simple instructions. The batteries are inserted into the device and the sample vial is placed in the test unit. The user then opens the test swab packet and rotates the swab five times in each nostril. The swab is then stirred in the sample vial, which is then gently pressed into the test unit to start the test. The "ready" light will blink until a "positive" or "negative" green light is illuminated within 30 minutes. In the US, Lucira also offers a free LUCI Pass™ digital verified test result back to a user's phone. LUCI Pass is accessed via text and does not require downloading an app. There is also an opt-in for public health reporting for users who wish to transmit their results to the relevant public health authorities. In clinical trials, 100% of users successfully performed the test at home in about two minutes using Lucira's easy-to-use 'swab, stir and detect' Check-It test kit. In a Community Trial setting, Lucira™ Check-It results were compared with the Hologic Panther Fusion, considered a high-sensitivity molecular test due to its low Limit of Detection ("LOD"). Lucira's accuracy was 98%, correctly detecting 385 out of 394 positive and negative samples in comparison to the Hologic Panther Fusion, excluding ten samples with very low levels of virus (those with very high PCR cycle thresholds of 37.5 or greater) that possibly no longer represented active infection. Comparative positive results agreed 97% of the time among this sample, and negative results agreed 98% of the time. About Lucira Health Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time. The Lucira™ Check-It COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit (Rx) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

Read More

HEALTH TECHNOLOGY

Sun Life Partners with CloudMD to Expand Mental Health Coach To All Group Benefits Clients

CloudMD Software & Services | November 30, 2021

The need to support Canadians and their mental health has never been greater. To help more people access care, Sun Life is expanding its partnership with CloudMD, the creators of Mental Health Coach. Following a successful seven-month pilot program, Sun Life will begin rolling out Mental Health Coach as part of its Group Benefits offering. Despite many Canadians experiencing mental health issues, a Sun Life study found over half are not seeking medical care. Cost, access, and feelings of embarrassment are the top barriers to blame. Sun Life and CloudMD are bridging the gap with Mental Health Coach. The service uses data analytics to identify Clients who are at risk of developing a mental health issue. It then proactively reaches out to guide Clients to the right resources and support. “As the largest provider of group benefits in Canada, we know that tackling the mental health crisis requires dedication and a customized approach. Each person experiences mental health in their own way – no two journeys are the same,” said Dave Jones, President, Sun Life Health. “We’re committed to providing Canadians with innovative and personalized mental health tools to help them wherever they are in their journey. Mental Health Coach is one way we’re helping our Clients live a healthier life.” A personalized and preventative approach to mental health A Mental Health Coach team member meets virtually or by phone with the plan member. They walk the plan member through a mental health assessment and create a personalized plan based on the benefits available to them. The Mental Health Coach service monitors the plan members’ progress and provides regular check-ins. They offer feedback and encouragement and can re-assess the plan member at any point in their journey. During the pilot, Sun Life worked closely with CloudMD to test and refine the Mental Health Coach service. Findings from the Mental Health Coach pilot include: 89% of those experiencing depression and 91% of those experiencing anxiety noticed ‘major improvements’. 73% said they have a better understanding of their benefits. 82% said they would recommend the service based on their own experience. 46% increase in plan members utilizing their mental health benefits for the first time. “We know that prevention is key when it comes to managing disability claims and connecting plan members with the care they need. The Mental Health Coach provides convenient and effective access to treatment. It can help with many mental health issues before they become severe, which can often lead to people going on disability.” Karen Adams, President, CloudMD Select Sun Life Group Benefits Clients will be able to access the Mental Health Coach service as part of their integrated benefits offering. The service will be rolled out and offered across plans throughout 2022. About Sun Life Sun Life is a leading international financial services organization providing insurance, wealth and asset management solutions to individual and corporate Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of September 30, 2021, Sun Life had total assets under management of $1.39 trillion.Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF. About CloudMD Software & Services CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the leading Student Assistance Program and one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers. CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America.

Read More

AI

InnerScope Hearing Technologies Announces Partnership with Atlazo Inc. to develop next-generation AI based hearable products

InnerScope Hearing Technologies, Inc. | November 12, 2021

InnerScope Hearing Technologies Inc.("InnerScope"), the leader in direct-to-consumer (DTC) and over-the-counter (OTC) hearing solutions, announced today its partnership with Atlazo Inc. ("Atlazo") to develop next-generation hearing aids and hearable products, utilizing Atlazo's patented Artificial Intelligence (AI) hardware platform. Hearing products powered by Atlazo's proprietary ultra-low power System-on-Chip (SoC) will offer consumers unprecedented new features, including voice commands, continuous health monitoring, and seamless connectivity with other smart devices. Mr. Adnan Shennib, Chief Technology Officer of InnerScope, stated: "Consumers will not only benefit from improved hearing in noisy environments but also from natural ways to interact with other wireless devices, including mobile phones, providing an enhanced, more convenient, user experience." Atlazo's integrated digital hardware platform reduces cost and time-to-market for manufacturers of wearable devices. The SoC platforms include software algorithms designed specifically for wearable healthcare applications. The Atlazo and InnerScope collaboration targeting hearing applications are protected by over 12 issued and pending patents. "We are pleased to join forces with InnerScope and its iHEAR team to develop new types of smart hearing products, leveraging iHEAR's extensive domain experience in hearing health," stated Karim Arabi, Founder and CEO of Atlazo. "Offering new types of intelligent hearing products with improved performance and affordability will be welcomed by tech-savvy consumers looking for alternatives to conventional hearing aids." "With the recent FDA OTC regulations being released last month, including a landmark proposal intended to improve access to and reduce the cost of hearing aid technology for millions of Americans, and the anticipation of this OTC Law to be enacted soon, InnerScope is continuing to execute its plan to be the leader in the direct-to-consumer hearing device market. The Atlazo partnership and our iHear research and development team give InnerScope the ability to develop new innovative types of proprietary artificial intelligence-powered hearing products that transcend today's hearing devices so all consumers, whether they have hearing loss or not, can benefit from using them." Matthew Moore, President and CEO of InnerScope Hearing Technologies About InnerScope Hearing Technologies, Inc InnerScope Hearing Technologies Inc. is a leading manufacturer and distributor of FDA-registered hearing aids and Personal Sound Amplifier Products (PSAPs) dedicated to addressing the global demand for affordable hearing solutions. InnerScope's hearing products and business models breakthrough persistent barriers that prevent access to effective hearing solutions. With the recent Acquisition of iHear Medical Inc., a cloud-based hearing solution provider with access to over 40 patents, and the completion of HearingAssist Acquisition, an established leader in the direct-to-consumer hearing aid market with over 400,000 customers, InnerScope is well-positioned to expand its distribution partnership network and its leadership in the direct-to-consumer hearing solutions market with advanced hearing products offered at a fraction of the cost of conventional hearing aids sold in hearing aid centers. About Atlazo Atlazo is the leader in intelligent semiconductor solutions for healthcare and wearable, targeting the rapidly growing hearing and wearable health device markets. Founded in 2016 and headquartered in San Diego, CA, the company is dedicated to addressing the global demand for more reliable health tracking and audio by bringing together cutting-edge innovations in energy-efficient AI and flexible bio-sensing interface in a single System-on-Chip (SoC) solution. Atlzao's innovative SoC products offer manufacturers a platform for rapid development of wearable healthcare products, dramatically reducing costs and time-to-market.

Read More

DIGITAL HEALTHCARE

Lucira Health Announces Expanded Partnership with Switch Health to Increase Canadians' Access to At-Home Molecular COVID-19 Tests

Lucira Health | December 27, 2021

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced a new agreement with Switch Health Solutions Inc. ("Switch Health") to increase Canadians' access to at-home molecular COVID-19 tests as Omicron cases surge. Lucira will provide more than 2 million at-home COVID-19 test kits in 2022 as part of the deal. "As Omicron cases surge around the world, the need for better testing solutions has never been more apparent. Only Lucira's tests provide a PCR-quality test result in 30 minutes, wherever you are, from a simple, single-use kit. Making these tests more available is critical to help slow the spread of COVID-19." Erik Engelson, President and Chief Executive Officer of Lucira Switch Health is a Canadian healthcare company dedicated to providing better decentralized patient care. Switch Health has quickly become a leader in COVID-19 testing on-site at its Switch Health Clinics and at-home through its remote telehealth service and in-person visits. "Switch Health's ability to be a Canadian health care leader in decentralized diagnostics is in large part due to the innovative technologies we make available to everyday Canadians," added Marc Thomson, Chief Operating Officer at Switch Health. "Lucira has been an instrumental partner in helping Switch Health achieve that in the COVID-19 era. Together, we are removing barriers to get Canadians safely back to work and reunited with their loved ones." Last month, Lucira announced confirmation that its COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' can detect 100% of Omicron variant genome sequences analyzed, including the "stealth variant." Lucira assays target viral sequence regions unaffected by the spike protein mutations found in Omicron, Delta, and other variants of concern, allowing it to maintain its accuracy in the face of an evolving virus. Lucira has received Interim Order authorization from Health Canada to sell and distribute its COVID-19 test kits for at-home self-testing in Canada. LUCIRA™ CHECK IT Test Kit The Lucira™ Check-It (OTC) and All-in-One (Rx) test kits are Nucleic-Acid Amplification Tests (referred to as NAAT). The tests fit in the palm of your hand, extract genetic material from the virus and amplify it, similar to PCR lab tests, to detect the presence of virus earlier and more accurately than antigen tests. The test uses an approach called reverse transcriptase loop-mediated isothermal amplification (RT-LAMP). It was designed and tested extensively for individuals to use independently and does not require a physician's prescription or supervised assistance. There is no additional equipment to purchase, such as a reader or instrument. Each Lucira test kit contains everything needed to run one COVID-19 test. Users get the test device, two AA batteries, sample vial, swab and simple instructions. The batteries are inserted into the device and the sample vial is placed in the test unit. The user then opens the test swab packet and rotates the swab five times in each nostril. The swab is then stirred in the sample vial, which is then gently pressed into the test unit to start the test. The "ready" light will blink until a "positive" or "negative" green light is illuminated within 30 minutes. In the US, Lucira also offers a free LUCI Pass™ digital verified test result back to a user's phone. LUCI Pass is accessed via text and does not require downloading an app. There is also an opt-in for public health reporting for users who wish to transmit their results to the relevant public health authorities. In clinical trials, 100% of users successfully performed the test at home in about two minutes using Lucira's easy-to-use 'swab, stir and detect' Check-It test kit. In a Community Trial setting, Lucira™ Check-It results were compared with the Hologic Panther Fusion, considered a high-sensitivity molecular test due to its low Limit of Detection ("LOD"). Lucira's accuracy was 98%, correctly detecting 385 out of 394 positive and negative samples in comparison to the Hologic Panther Fusion, excluding ten samples with very low levels of virus (those with very high PCR cycle thresholds of 37.5 or greater) that possibly no longer represented active infection. Comparative positive results agreed 97% of the time among this sample, and negative results agreed 98% of the time. About Lucira Health Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time. The Lucira™ Check-It COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit (Rx) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

Read More

HEALTH TECHNOLOGY

Sun Life Partners with CloudMD to Expand Mental Health Coach To All Group Benefits Clients

CloudMD Software & Services | November 30, 2021

The need to support Canadians and their mental health has never been greater. To help more people access care, Sun Life is expanding its partnership with CloudMD, the creators of Mental Health Coach. Following a successful seven-month pilot program, Sun Life will begin rolling out Mental Health Coach as part of its Group Benefits offering. Despite many Canadians experiencing mental health issues, a Sun Life study found over half are not seeking medical care. Cost, access, and feelings of embarrassment are the top barriers to blame. Sun Life and CloudMD are bridging the gap with Mental Health Coach. The service uses data analytics to identify Clients who are at risk of developing a mental health issue. It then proactively reaches out to guide Clients to the right resources and support. “As the largest provider of group benefits in Canada, we know that tackling the mental health crisis requires dedication and a customized approach. Each person experiences mental health in their own way – no two journeys are the same,” said Dave Jones, President, Sun Life Health. “We’re committed to providing Canadians with innovative and personalized mental health tools to help them wherever they are in their journey. Mental Health Coach is one way we’re helping our Clients live a healthier life.” A personalized and preventative approach to mental health A Mental Health Coach team member meets virtually or by phone with the plan member. They walk the plan member through a mental health assessment and create a personalized plan based on the benefits available to them. The Mental Health Coach service monitors the plan members’ progress and provides regular check-ins. They offer feedback and encouragement and can re-assess the plan member at any point in their journey. During the pilot, Sun Life worked closely with CloudMD to test and refine the Mental Health Coach service. Findings from the Mental Health Coach pilot include: 89% of those experiencing depression and 91% of those experiencing anxiety noticed ‘major improvements’. 73% said they have a better understanding of their benefits. 82% said they would recommend the service based on their own experience. 46% increase in plan members utilizing their mental health benefits for the first time. “We know that prevention is key when it comes to managing disability claims and connecting plan members with the care they need. The Mental Health Coach provides convenient and effective access to treatment. It can help with many mental health issues before they become severe, which can often lead to people going on disability.” Karen Adams, President, CloudMD Select Sun Life Group Benefits Clients will be able to access the Mental Health Coach service as part of their integrated benefits offering. The service will be rolled out and offered across plans throughout 2022. About Sun Life Sun Life is a leading international financial services organization providing insurance, wealth and asset management solutions to individual and corporate Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of September 30, 2021, Sun Life had total assets under management of $1.39 trillion.Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF. About CloudMD Software & Services CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the leading Student Assistance Program and one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers. CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America.

Read More

AI

InnerScope Hearing Technologies Announces Partnership with Atlazo Inc. to develop next-generation AI based hearable products

InnerScope Hearing Technologies, Inc. | November 12, 2021

InnerScope Hearing Technologies Inc.("InnerScope"), the leader in direct-to-consumer (DTC) and over-the-counter (OTC) hearing solutions, announced today its partnership with Atlazo Inc. ("Atlazo") to develop next-generation hearing aids and hearable products, utilizing Atlazo's patented Artificial Intelligence (AI) hardware platform. Hearing products powered by Atlazo's proprietary ultra-low power System-on-Chip (SoC) will offer consumers unprecedented new features, including voice commands, continuous health monitoring, and seamless connectivity with other smart devices. Mr. Adnan Shennib, Chief Technology Officer of InnerScope, stated: "Consumers will not only benefit from improved hearing in noisy environments but also from natural ways to interact with other wireless devices, including mobile phones, providing an enhanced, more convenient, user experience." Atlazo's integrated digital hardware platform reduces cost and time-to-market for manufacturers of wearable devices. The SoC platforms include software algorithms designed specifically for wearable healthcare applications. The Atlazo and InnerScope collaboration targeting hearing applications are protected by over 12 issued and pending patents. "We are pleased to join forces with InnerScope and its iHEAR team to develop new types of smart hearing products, leveraging iHEAR's extensive domain experience in hearing health," stated Karim Arabi, Founder and CEO of Atlazo. "Offering new types of intelligent hearing products with improved performance and affordability will be welcomed by tech-savvy consumers looking for alternatives to conventional hearing aids." "With the recent FDA OTC regulations being released last month, including a landmark proposal intended to improve access to and reduce the cost of hearing aid technology for millions of Americans, and the anticipation of this OTC Law to be enacted soon, InnerScope is continuing to execute its plan to be the leader in the direct-to-consumer hearing device market. The Atlazo partnership and our iHear research and development team give InnerScope the ability to develop new innovative types of proprietary artificial intelligence-powered hearing products that transcend today's hearing devices so all consumers, whether they have hearing loss or not, can benefit from using them." Matthew Moore, President and CEO of InnerScope Hearing Technologies About InnerScope Hearing Technologies, Inc InnerScope Hearing Technologies Inc. is a leading manufacturer and distributor of FDA-registered hearing aids and Personal Sound Amplifier Products (PSAPs) dedicated to addressing the global demand for affordable hearing solutions. InnerScope's hearing products and business models breakthrough persistent barriers that prevent access to effective hearing solutions. With the recent Acquisition of iHear Medical Inc., a cloud-based hearing solution provider with access to over 40 patents, and the completion of HearingAssist Acquisition, an established leader in the direct-to-consumer hearing aid market with over 400,000 customers, InnerScope is well-positioned to expand its distribution partnership network and its leadership in the direct-to-consumer hearing solutions market with advanced hearing products offered at a fraction of the cost of conventional hearing aids sold in hearing aid centers. About Atlazo Atlazo is the leader in intelligent semiconductor solutions for healthcare and wearable, targeting the rapidly growing hearing and wearable health device markets. Founded in 2016 and headquartered in San Diego, CA, the company is dedicated to addressing the global demand for more reliable health tracking and audio by bringing together cutting-edge innovations in energy-efficient AI and flexible bio-sensing interface in a single System-on-Chip (SoC) solution. Atlzao's innovative SoC products offer manufacturers a platform for rapid development of wearable healthcare products, dramatically reducing costs and time-to-market.

Read More

Events